Fundraising FoxSpectrumedics
Shanghai, CN · 3 known investors
Find your way into Spectrumedics
Sign up to see every warm intro you have to Spectrumedics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spectrumedics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
Investors · 3
.jpeg){kind=logo}
B Capital Grouplisted by B Capital GroupSan Francisco · $10M – $50M
How we know: B Capital Group's portfolio page · the VCSheet dataset · Not right? Tell us
Legend CapitalreportedBeijing · $2M – $10M
How we know: press coverage · Not right? Tell us
Frequently asked questions
- What does Spectrumedics do?
- Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
- Who are Spectrumedics's investors?
- Spectrumedics's investors include B Capital Group, B4 Capital, Legend Capital.
- Where is Spectrumedics headquartered?
- Spectrumedics is headquartered in Shanghai, CN.